Showing results (31-40 of 123) with videos related to
Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remissionM Ryan Corces-Zimmerman, Wan-Jen Hong, Irving L Weissman, et al.Cancer|August 13, 2015
Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in CaliforniaRenata Abrahão, Raul C Ribeiro, Bruno C Medeiros, et al.Annals of Hematology|March 21, 2015
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United StatesBruno C Medeiros, Sacha Satram-Hoang, Deborah Hurst, et al.American Journal of Hematology|April 5, 2019
Optimizing survival outcomes with post-remission therapy in acute myeloid leukemiaBruno C Medeiros, Steven M Chan, Naval G Daver, et al.Leukemia & Lymphoma|April 12, 2022
Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemiaEugenia Miranti, Dora Y Ho, Kyle Enriquez, et al.Human Pathology|December 8, 2014
Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasmDinesh Rakheja, Franklin Fuda, Travis Vandergriff, et al.Cancer Discovery|June 21, 2015
Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to TherapyGregory K Behbehani, Nikolay Samusik, Zach B Bjornson, et al.Expert Opinion on Therapeutic Targets|January 12, 2011
Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancerMeng Wang, Bruno C Medeiros, Harry P Erba, et al.Proceedings of the National Academy of Sciences of the United States of America|December 21, 2005
The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatasesAlexander Ungewickell, Christopher Hugge, Marina Kisseleva, et al.Haematologica|December 3, 2011
Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemiaRoland B Walter, Bruno C Medeiros, Bayard L Powell, et al.Pageof 13